⌘K

Login Start Free

Home/Filings/4/0000875320-24-000189

4//SEC Filing

Bozic Carmen 4

Accession 0000875320-24-000189

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Jul 24, 8:00 PM ET

Accepted

Jul 25, 4:06 PM ET

Size

4.7 KB

Accession

0000875320-24-000189

Insider Transaction Report

Form 4

Period: 2024-07-24

VERTEX PHARMACEUTICALS INC / MAVRTX

EVP and CMO

Transactions

Sale
Common Stock
2024-07-24$488.46/sh−2,280$1,113,689→ 25,539 total

Footnotes (1)

[F1]Transaction made pursuant to Dr. Bozic's company approved trading plan under Rule 10b5-1, which was entered into on 02/27/2024.

Documents

1 file

4
wk-form4_1721937956.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001790029

Filing Metadata

Form type: 4
Filed: Jul 24, 8:00 PM ET
Accepted: Jul 25, 4:06 PM ET
Size: 4.7 KB

View on SEC.gov